AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
0.81%59.961.4%$1550.16m
JNJJohnson & Johnson
0.56%140.340.7%$880.30m
PFEPfizer Inc.
0.71%38.300.9%$769.20m
MRKMerck & Co., Inc.
0.10%88.840.7%$670.35m
ABBVAbbVie, Inc.
0.32%87.002.3%$649.82m
LLYEli Lilly & Co.
-0.14%119.601.1%$340.88m
AZNAstraZeneca Plc
0.13%47.681.2%$136.29m
RETAReata Pharmaceuticals, Inc.
-0.12%199.323.5%$133.57m
GSKGlaxoSmithKline Plc
0.66%45.510.2%$128.61m
NVSNovartis AG
0.34%91.950.2%$128.17m
KRTXKaruna Therapeutics, Inc.
3.35%67.630.0%$101.66m
NVONovo Nordisk A/S
-0.59%56.740.1%$92.77m
SNYSanofi
-0.11%46.030.2%$69.98m
ALLKAllakos, Inc.
-4.63%117.360.0%$64.39m
BHVNBiohaven Pharmaceutical Holding Co. Ltd.
2.05%54.860.0%$38.47m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.